Cybin Inc N.CYBN

Alternate Symbol(s): CYBN

Healthcare Drug Manufacturers - Specialty & Generic

Cybin Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company creates psychedelic-based therapeutics to address the unmet need for treatment options for people who suffer from mental health conditions. Its N,N-dimethyltryptamine (DMT) and dDMT programs creates a dataset of systematic research on these psychedelic molecules. The Company is developing CYB003, a proprietary deuterated psilocybin analog for the treatment of major depressive disorder and CYB004, a proprietary deuterated dDMT molecule for generalized anxiety disorder and has a research pipeline of investigational psychedelic-based compounds. CYB003 moves to Phase III and CYB004 moves to Phase II. It has an intellectual property portfolio in the psychedelic drug development sector with over 30 patents granted and 160 patents pending. The Company operates in Canada, the United States, the United Kingdom, the Netherlands and Ireland.

NEO:CYBN - Post by User

Cybin Inc > CyBin Acquisition

<< Previous

Bullboard Posts

Next >>

Post by Jim1274on Dec 08, 2020 11:21am

233 Views

Post# 32057832

CyBin Acquisition

So did Cybin actually just manage to buy a company with multiple patents and years of intellectual property for 6million shares?? Then an additional 6m shares “IF” they meet expectations..?? Sounds like a crazy deal and a good way to insure the team works their toushies off to get this thing done!! Opinions?? Did I miss something??

<< Previous

Bullboard Posts

Next >>

Three micro-cap value stocks trading at peak pessimism